INS and type 2 diabetes mellitus: In addition, LPS can also release inflammatory factors by combining with corresponding receptors in insulin target organs, such as the liver, and fat tissue, thereby disrupting the insulin signaling pathway and insulin receptor expression, ultimately reducing insulin efficacy and leading to the occurrence of T2DM (Singer-Englar et al., 2019).